| 000 | 01775 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517044350.0 | ||
| 264 | 0 | _c20160419 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1873-5487 | ||
| 024 | 7 |
_a10.1016/j.arcmed.2015.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJaime-Pérez, José Carlos | |
| 245 | 0 | 0 |
_aNon-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma. _h[electronic resource] |
| 260 |
_bArchives of medical research _cAug 2015 |
||
| 300 |
_a454-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGamboa-Alonso, Carmen Magdalena | |
| 700 | 1 | _aVázquez-Mellado de Larracoechea, Alberto | |
| 700 | 1 | _aRodríguez-Martínez, Marisol | |
| 700 | 1 | _aGutiérrez-Aguirre, César Homero | |
| 700 | 1 | _aMarfil-Rivera, Luis Javier | |
| 700 | 1 | _aGómez-Almaguer, David | |
| 773 | 0 |
_tArchives of medical research _gvol. 46 _gno. 6 _gp. 454-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.arcmed.2015.07.004 _zAvailable from publisher's website |
| 999 |
_c25132440 _d25132440 |
||